22nd Century Group Offloads Hemp/Cannabis Franchise In $2.25M Deal, Seeks To ‘Reduce Cash And Operating Demands’
22nd Century Group, Inc. (NASDAQ: XXII) confirmed Tuesday it has reached an agreement to sell "substantially all" of its GVB Biopharma hemp/cannabis operations to Specialty Acquisition Corporation, a Nevada company.